Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Polymer-based or polymer-free stents in patients at high bleeding risk: ONYX ONE

24 Feb 2020

The objective of the ONYX ONE study was to compare the safety and effectiveness of the polymer-based or polymer-free stents in patients at high bleeding risk receiving 1 month of DAPT.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Polymer-based or polymer-free stents in patients at high bleeding risk: ONYX ONE

Defining device success for PCI trials

05 Feb 2020

Percutaneous coronary intervention with implantation of drug-eluting stents has become the most commonly performed revascularisation procedure in patients with symptomatic coronary artery disease. Continuous iterations of coronary devices incorporating changes in platform materials, geometry, strut thickness, drug release mechanisms and antiproliferative drugs have progressively reduced the rate...

Authors :

C. Chin Chang, N. Kogame, Y. Onuma, R. A. Byrne, D. Capodanno, S. Windecker, M.-A. Morel, D. E. Cutlip , M. W. Krucoff, G. W. Stone , A. J. Lansky, R. Mehran , E. Spitzer, A. G. Fraser, A. Baumbach, P. W. Serruys
EuroIntervention: Defining device success for PCI trials

Oval stenting in left pulmonary artery stenosis: a novel double balloon technique to prevent airway compression in single ventricle

29 Jan 2020

Left pulmonary artery (LPA) stenosis is common in patients with cavopulmonary connections. Stent implantation is the treatment of choice but may be complicated or contraindicated by left main bronchus (LMB) compression due to limited retro-aortic space after a Damus-Kaye-Stansel (DKS) or Norwood operation. This study describes...

Authors :

G. J. Krings, F. van der Stelt, M. M.C. Molenschot, J. M.P.J. Breur
EuroIntervention: Oval LPA stenting to prevent LMB compression

Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial

31 Jan 2020

In IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions) trial the long-term outcomes of stent optimisation with IVUS were analysed.

Babu Ezhumalai

Reviewer

Babu Ezhumalai

Reviewer

Salvatore Brugaletta
Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial

Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial

21 Jan 2020

This study aimed at comparing the effects of fractional flow reserve- vs. optical coherence tomography-guided treatment of angiographically intermediate coronary stenosis.

Dejan Milasinovic

Reviewer

Dejan Milasinovic
Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis: a single-center trial

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent vs a durable fluoropolymer-based everolimus-eluting stent in patients with CAD: the ANGIOLITE trial

14 Jan 2020

The durable fluoroacrylate polymer-based sirolimus-eluting stent (Angiolite SES) has shown promising preclinical and clinical results regarding inflammatory vascular reaction and neointimal healing. J. Moreu, et al. aimed to compare performance between the Angiolite SES and an everolimus-eluting stent (EES) in patients with coronary artery disease.

Authors :

J. Moreu, R. Moreno-Gómez, A. Pérez de Prado, B. García del Blanco, R. Trillo, E. Pinar, E. Molina, J. Zueco, A. Merchán, J. Francisco Díaz-Fernández, I. Amat
EuroIntervention: the ANGIOLITE trial

Complex and challenging cases II

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!

Complex and challenging cases II

Interactive Case Corner 6 - SCAD, LMS lesions & stent thrombosis

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn from complex clinical cases, how to manage challenging scenarios and complications, such as SCAD in three different vessels, acute stent thrombosis, LMS lesions, and more!

Interactive Case Corner 6 - SCAD, LMS lesions & stent thrombosis

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn from challenging clinical cases how to manage various complications, such as SVG thrombosis in STEMI, twisted coronary catheter, total stent loss and more!

Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss

Interactive Case Corner 9 - Complex TAVI & PCI

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover a selection of complex PCI and TAVI cases, such as TAVR in low-lying coronary ostium and narrow sinus of valsalva, complex left main primary PCI for a patient with cardiogenic shock, renal disease with bilateral critical renal artery stenosis, and more!

Interactive Case Corner 9 - Complex TAVI & PCI